Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.
|Videos|April 6, 2020
Telemedicine can help practices thrive during the COVID-19 crisis
Author(s)Jessica Barry
Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, discusses telemedicine in the era of COVID-19.
Advertisement
In this brief interview, Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, highlights some of recent changes to the Centers for Medicare & Medicaid Services telehealth coverage policy. He also offers advice to colleagues implementing changes to their practice during the COVID-19 crisis, and discusses how this pandemic may give providers the chance to prove the efficacy of telemedicine for future practice.
For more guidance, please visit
Advertisement
Related to this article
Falk G. Bechara, MD, discusses long-term tunnel control, structural damage, and the evolving role of biologics and surgery in HS care.
Galderma has agreed to acquire ZO Skin Health for $1.5 billion, adding the physician-dispensed skincare brand to a portfolio that already includes Cetaphil and Alastin.
New dermatology research explores hidden steroids in OTC products, infant eczema, melanoma prevention, cutaneous lymphoma, and pediatric AD.
SYX-5219 improved disease severity and itch in a Phase 1b trial of adults with moderate to severe atopic dermatitis.
In a survey of 301 employed adults, overall work impairment attributable to CHE was 31.8%, and quality of life worsened in step with self-reported disease severity.
An analysis of 633 skincare brands found gaps in evidence, safety information, and claim support, raising questions about what patients can verify online.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
Galderma to Acquire ZO Skin Health for $1.5 Billion
2
Alopecia Areata Is a Medical Disease: Treatment Options and Defining Severity
3
First-in-Class Oral PKM2 Modulator Shows Early Efficacy in Atopic Dermatitis
4
Chronic Hand Eczema Linked to Lost Productivity and Lower Quality of Life
5